Sector
PharmaceuticalsOpen
₹956.6Prev. Close
₹1,028.9Turnover(Lac.)
₹1.07Day's High
₹974.9Day's Low
₹956.652 Week's High
₹1,30352 Week's Low
₹709Book Value
₹423.66Face Value
₹10Mkt Cap (₹ Cr.)
116.28P/E
21.84EPS
47.12Divi. Yield
0.34Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 1.2 | 1.2 | 1.2 | 1.2 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 44.43 | 39.11 | 35.69 | 30.78 |
Net Worth | 45.63 | 40.31 | 36.89 | 31.98 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 68.6 | 57.26 | 51.86 | 48.02 |
yoy growth (%) | 19.78 | 10.41 | 7.99 | 1.07 |
Raw materials | -31.16 | -25.64 | -23.83 | -20.22 |
As % of sales | 45.43 | 44.77 | 45.94 | 42.11 |
Employee costs | -9.79 | -9.3 | -7.33 | -6.9 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 7.9 | 4.32 | 2.45 | 4.89 |
Depreciation | -1.92 | -1.86 | -1.47 | -1.28 |
Tax paid | -2.57 | -1.1 | -0.44 | -2.19 |
Working capital | 2.51 | 0.57 | 1.74 | 3.08 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 19.78 | 10.41 | 7.99 | 1.07 |
Op profit growth | 55.54 | 40.92 | -34.9 | 3.8 |
EBIT growth | 66.14 | 53.04 | -41.88 | -4.64 |
Net profit growth | 65.34 | 60.34 | -25.51 | -31.08 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
ED / MD / Promoter
Rajendra R Shah
Non Executive Director
Dilip R Shah
Chairman & Independent Directo
Divyakant Ramniklal Zaveri
Independent Non Exe. Director
Bharat Dhirajlal Mehta
Non-Exec & Non-Independent Dir
Paresh Mistry
Non Executive Director
Janki Shah
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Mercury Laboratories Ltd
Summary
Mercury Laboratories Ltd the registered partnership firm started its business activity in the year 1962. Subsequently it converted into Private Ltd. Company, & incorporated in the year February 02nd, 1982. Later it further converted into Limited Company in the year 1992 in state of Maharashtra. The Company is engaged in the business of Pharmaceutical items, medicinal drugs and formulations. It is a profit making and dividend paying public limited company.
Read More
The Mercury Laboratories Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹969 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mercury Laboratories Ltd is ₹116.28 Cr. as of 22 Jul ‘24
The PE and PB ratios of Mercury Laboratories Ltd is 21.84 and 2.43 as of 22 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Mercury Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Mercury Laboratories Ltd is ₹709 and ₹1303 as of 22 Jul ‘24
Mercury Laboratories Ltd's CAGR for 5 Years at 31.27%, 3 Years at 12.63%, 1 Year at 27.34%, 6 Month at -12.44%, 3 Month at 21.62% and 1 Month at 12.92%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.